These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2077866)

  • 41. Antibody responses to intradermal recombinant hepatitis B immunization among HIV-positive subjects.
    Ristola MA; Vuola JM; Valle M; von Reyn CF
    Vaccine; 2004 Nov; 23(2):205-9. PubMed ID: 15531038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anticaries vaccination: present and future prospects].
    Mosci F; Marconi PF
    Minerva Stomatol; 1989 Mar; 38(3):379-88. PubMed ID: 2657371
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Engerix B vaccine in prophylaxis of hepatitis B virus infection in children with diabetes].
    Tańska A
    Wiad Lek; 1994 Feb; 47(3-4):107-10. PubMed ID: 7975633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New strategies against an old plague: genetically engineered tuberculosis vaccines.
    Dreher D; Kok M; Pechère JC; Nicod LP
    Schweiz Med Wochenschr; 2000 Dec; 130(50):1925-9. PubMed ID: 11189437
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunization with targeted fusion anticaries DNA vaccine via intramuscular route:experiment with murine].
    Yu F; Fan MW; Xu QA; Jia R; Guo JH; Bian Z; Chen Z; Peng B; Fan B
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):754-9. PubMed ID: 15200917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatitis B vaccines.
    Zuckerman AJ
    Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Vaccination against hepatitis virus B infection. Vaccine from inactivated HBsAg positive plasma or recombinant vaccine?].
    Horejsí J
    Cas Lek Cesk; 1987 Jul; 126(31):981-2. PubMed ID: 2959363
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of a recombinant yeast-derived hepatitis B vaccine in healthy adults.
    Scheiermann N; Gesemann KM; Kreuzfelder E; Paar D
    Postgrad Med J; 1987; 63 Suppl 2():115-9. PubMed ID: 3317345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The status of anti-caries vaccine research and consideration].
    Fan MW
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2009 Feb; 44(2):65-8. PubMed ID: 19563035
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetically engineered vaccines.
    Hughes JA; Brazeau GA
    Am Pharm; 1995 Dec; NS35(12):9-10. PubMed ID: 8546075
    [No Abstract]   [Full Text] [Related]  

  • 53. Life-style vaccines.
    Mettens P; Monteyne P
    Br Med Bull; 2002; 62():175-86. PubMed ID: 12176859
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biotechnological trends towards synthetic vaccines.
    Liew FY
    Immunol Lett; 1988 Nov; 19(3):241-4. PubMed ID: 3235114
    [No Abstract]   [Full Text] [Related]  

  • 55. Vaccines, cells, and nucleic acids. Workshop on vaccines prepared in continuous mammalian cell lines and by recombinant systems. London, July 1989. Proceedings.
    J Med Virol; 1990 May; 31(1):1-66. PubMed ID: 2376724
    [No Abstract]   [Full Text] [Related]  

  • 56. [Pure vaccinations in spite of common syringe; new construction for prevention of vaccinal hepatitis and poliomyelitis].
    GROSS WO
    Dtsch Med Wochenschr; 1954 May; 79(20):829-31. PubMed ID: 13161619
    [No Abstract]   [Full Text] [Related]  

  • 57. Vaccination of adults against travel-related infectious diseases, and new developments in vaccines.
    Döller PC
    Infection; 1993; 21(1):1-17. PubMed ID: 8449574
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Biotechnology and vaccinations].
    Peret R
    Actual Odontostomatol (Paris); 1990 Dec; (172):663-74. PubMed ID: 2077866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Synthetic vaccines for immunization against infection with hepatitis B virus].
    Horejsí J
    Cas Lek Cesk; 1989 Feb; 128(7):193-7. PubMed ID: 2524258
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fish vaccine antigens produced or delivered by recombinant DNA technologies.
    Leong JC; Anderson E; Bootland LM; Chiou PW; Johnson M; Kim C; Mourich D; Trobridge G
    Dev Biol Stand; 1997; 90():267-77. PubMed ID: 9270855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.